Sign in Register Copyright © 2026 Illumina Inc. All Rights Reserved
Build:
Version: 2.8.0.
Clear Search sequence regions


Optimization of the lead compound 2-[-4-(4-chloro-benzyl)-piperazin-1-yl]-1-(2,3-dihydro-indol-1-yl)-ethanone 1 by systematic structure-activity relation (SAR) studies lead to two potent compounds 2-[-4-(4-chloro-benzyl)-piperazin-1-yl]-1-(2-methy-2,3-dihydro-indol-1-yl)-ethanone 2n and 2-[-4-(4-chloro-benzyl)-piperazin-1-yl]-1-(2-methy-2,3-dihydro-indol-1-yl)-ethanone 7b. Their related synthesis was also reported.

Citation

He Zhao, Andrew Thurkauf, Xiaoshu He, Kevin Hodgetts, Xiaoyan Zhang, Stanislaw Rachwal, Renata X Kover, Alan Hutchison, John Peterson, Andrzej Kieltyka, Robbin Brodbeck, Renee Primus, Jan W F Wasley. Indoline and piperazine containing derivatives as a novel class of mixed D(2)/D(4) receptor antagonists. Part 1: identification and structure-activity relationships. Bioorganic & medicinal chemistry letters. 2002 Nov 4;12(21):3105-9

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 12372512

View Full Text